EMFAT
PTLA

Emerald Mutual Fund Advisers Trust’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-188,640
Closed -$4.5M – 336
2019
Q4 		$4.5M Sell
188,640
-280,344
-60% -$7.73M 0.18% 141
2019
Q3 		$12.6M Sell
468,984
-6,950
-1% -$195K 0.56% 61
2019
Q2 		$12.9M Buy
475,934
+102,155
+27% +$3.2M 0.51% 74
2019
Q1 		$13M Buy
+373,779
New +$10.8M 0.52% 63
2018
Q1 		– Sell
-443,328
Closed -$21.6M – 271
2017
Q4 		$21.6M Buy
443,328
+68,420
+18% +$3.46M 0.86% 32
2017
Q3 		$20.3M Buy
374,908
+12,197
+3% +$716K 0.84% 33
2017
Q2 		$20.4M Buy
362,711
+147,270
+68% +$5.9M 0.89% 37
2017
Q1 		$8.44M Sell
215,441
-171,252
-44% -$5.45M 0.39% 93
2016
Q4 		$8.68M Sell
386,693
-348,842
-47% -$6.81M 0.41% 87
2016
Q3 		$16.7M Buy
735,535
+99,009
+16% +$2.32M 0.85% 37
2016
Q2 		$15M Buy
636,526
+199,162
+46% +$4.92M 0.84% 38
2016
Q1 		$8.92M Buy
437,364
+234,370
+115% +$7.44M 0.5% 79
2015
Q4 		$10.4M Buy
202,994
+10,730
+6% +$520K 0.55% 76
2015
Q3 		$8.19M Sell
192,264
-122,425
-39% -$5.91M 0.54% 67
2015
Q2 		$14.3M Sell
314,689
-42,294
-12% -$1.7M 1.11% 24
2015
Q1 		$12.9M Buy
356,983
+19,800
+6% +$680K 1.06% 26
2014
Q4 		$9.55M Buy
337,183
+52,972
+19% +$1.47M 0.83% 46
2014
Q3 		$7.18M Buy
284,211
+83,190
+41% +$2.19M 0.69% 56
2014
Q2 		$5.87M Buy
201,021
+3,471
+2% +$84K 0.54% 73
2014
Q1 		$5.12M Sell
197,550
-123,010
-38% -$3.28M 0.49% 81
2013
Q4 		$8.48M Buy
320,560
+174,610
+120% +$4.24M 0.51% 77
2013
Q3 		$3.9M Buy
145,950
+6,601
+5% +$157K 0.54% 70
2013
Q2 		$3.42M Buy
+139,349
New +$2.77M 0.58% 68

Other funds holding PTLA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's PTLA Position: Q1 2020 in Review

Emerald Mutual Fund Advisers Trust sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2020, closing a stake of 188,640 shares — an estimated $4.5M sold.

Emerald Mutual Fund Advisers Trust first reported a position in PTLA in Q2 2013 and held it in 23 quarters. The position peaked at $21.6M in Q4 2017. 187 funds tracked by Wall St. Rank hold PTLA as of Q1 2020.

  • Emerald Mutual Fund Advisers Trust reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
  • Emerald Mutual Fund Advisers Trust sold 188,640 Portola Pharmaceuticals, Inc. shares in Q1 2020, an estimated $4.5M.
  • Emerald Mutual Fund Advisers Trust first reported a position in Portola Pharmaceuticals, Inc. in Q2 2013 and held it in 23 quarters.
  • Emerald Mutual Fund Advisers Trust's Portola Pharmaceuticals, Inc. position peaked at $21.6M in Q4 2017.
  • 187 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2020.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q1 2020, filed 30 Apr 2020.